CHIARINI, FRANCESCA

CHIARINI, FRANCESCA  

DIPARTIMENTO DI SCIENZE BIOMEDICHE E NEUROMOTORIE  

Personale esterno ed autonomi  

Mostra records
Risultati 1 - 20 di 40 (tempo di esecuzione: 0.049 secondi).
Titolo Autore(i) Anno Periodico Editore Tipo File
Antigene MYCN Silencing by BGA002 Inhibits SCLC Progression Blocking mTOR Pathway and Overcomes Multidrug Resistance Bortolotti, Sonia; Angelucci, Silvia; Montemurro, Luca; Bartolucci, Damiano; Raieli, Salvatore; L...ampis, Silvia; Amadesi, Camilla; Scardovi, Annalisa; Nieddu, Giammario; Cerisoli, Lucia; Paganelli, Francesca; Chiarini, Francesca; Teti, Gabriella; Falconi, Mirella; Pession, Andrea; Hrelia, Patrizia; Tonelli, Roberto 2023-01-01 CANCERS - 1.01 Articolo in rivista cancers-15-00990.pdf
Assessment of the structural and functional characteristics of human mesenchymal stem cells associated with a prolonged exposure of morphine Carano F.; Teti G.; Ruggeri A.; Chiarini F.; Giorgetti A.; Mazzotti M.C.; Fais P.; Falconi M. 2021-01-01 SCIENTIFIC REPORTS - 1.01 Articolo in rivista 41598_2021_Article_98682.pdf41598_2021_98682_MOESM1_ESM.pdf
Cellular senescence in vascular wall mesenchymal stromal cells, a possible contribution to the development of aortic aneurysm Teti G.; Chiarini F.; Mazzotti E.; Ruggeri A.; Carano F.; Falconi M. 2021-01-01 MECHANISMS OF AGEING AND DEVELOPMENT - 1.01 Articolo in rivista 1-s2.0-S0047637421000877-main.pdf1-s2.0-S0047637421000877-mmc1.docx
Inhibition of methyltransferase dot1l sensitizes to sorafenib treatment aml cells irrespective of mll-rearrangements: A novel therapeutic strategy for pediatric aml Lonetti A.; Indio V.; Laginestra M.A.; Tarantino G.; Chiarini F.; Astolfi A.; Bertuccio S.N.; Mar...telli A.M.; Locatelli F.; Pession A.; Masetti R. 2020-01-01 CANCERS - 1.01 Articolo in rivista cancers-12-01972.pdfcancers-12-01972-s001.zip
Lamin A and prelamin A counteract invasiveness of osteosarcoma cells Camilla Evangelisti, Francesca Paganelli, Gaia Giuntini, Elisabetta Mattioli, Alessandra Cappelli...ni, Giulia Ramazzotti, Irene Faenza, Maria Cristina Maltarello, Alberto M. Martelli, Katia Scotlandi, Francesca Chiarini, Giovanna Lattanzi 2020-01-01 CELLS - 1.01 Articolo in rivista cells-09-00774.pdfcells-09-00774-s001.zip
The role played by Wnt/beta-catenin signaling pathway in acute lymphoblastic leukemia. Francesca Chiarini, Francesca Paganelli, Alberto M Martelli, Camilla Evangelisti. 2020-01-01 INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES - 1.01 Articolo in rivista ijms-21-01098.pdf
The unfolded protein response: a novel therapeutic target in acute leukemias. A.M. Martelli, F. Paganelli, F. Chiarini, C. Evangelisti, J. J.A. McCubrey. 2020-01-01 CANCERS - 1.01 Articolo in rivista cancers-12-00333-v2.pdf
Lamin A acts a tumor suppressor in Ewing sarcoma promoting neural differentiation and reducing cell migration and invasion Chiarini F, Balestra T, Fazio A, Paganelli F, Maltarello MC, Evangelisti C, Capanni C, Petrini S,... Martelli AM, Lattanzi G, Scotlandi K 2019-01-01 - - 4.03 Poster -
Targeting metabolic vulnerabilities and aberrant signal transduction pathways in paediatric T-cell Acute Lymphoblastic Leukaemia (T-ALL) Laura Anselmi, Benedetta Accordi, Valentina Serafin, Manuela Zavatti, Luca Braglia, Maddalena Pag...anin,
Francesca Chiarini, Silvia Bresolin, Shaun Patterson, Maria Ruzzene, Alberto Maria Martelli, Giuseppe Basso, Xu
Huang, Sandra Marmiroli
2019-01-01 - - 4.02 Riassunto (Abstract) -
PI3K pan-inhibition impairs more efficiently proliferation and survival of T-cell acute lymphoblastic leukemia cell lines when compared to isoform-selective PI3K inhibitors. Annalisa Lonetti, Alessandra Cappellini, Antonino Maria Spartà, Francesca Chiarini, Francesca Buo...ntempo, Camilla Evangelisti, Cecilia Evangelisti, Ester Orsini, James A. McCubrey, Alberto Maria Martelli 2015-01-01 ONCOTARGET - 1.01 Articolo in rivista PI3K pan inhibition impairs more efficiently proliferation and survival of T cell acute lymphoblastic leukemia cell lines when compared to isoform selective PI3K inhibitors..pdf
A COMBINATION OF BORTEZOMIB WITH CX-4945, A CASEIN KINASE 2 (CK2) INHIBITOR, HAS SYNERGISTIC CYTOTOXIC EFFECTS IN ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) CELL LINES Buontempo, Francesca; Orsini, E; Cappellini, Alessandra; Lonetti, Annalisa; Evangelisti, C; Chiar...ini, Francesca; Spartà, Am; Bressanin, D; Evangelisti, C; Martelli, Am 2014-01-01 HAEMATOLOGICA - 4.02 Riassunto (Abstract) -
ASSESSMENT OF THE EFFECT OF SPHINGOSINE KINASE INHIBITORS ON APOPTOSIS, UNFOLDED PROTEIN RESPONSE AND AUTOPHAGY OF T-ACUTE LYMPHOBLASTIC LEUKEMIA CELLS: INDICATIONS FOR NOVEL THERAPEUTICS Evangelisti, C; Evangelisti, C; Teti, G; Falconi, M; Cappellini, A; Chiarini, F; Buontempo, F; Br...essanin, D; Lonetti, A; Spartà, A; Bittman, R; Pyne, S; Pyne, N; Martelli, Am 2014-01-01 HAEMATOLOGICA - 4.02 Riassunto (Abstract) -
A role of PI-PLCb1 in G1/S transition in human erythroleukemia k562 cells Alessandro Poli; Irene Faenza; Alessandro Matteucci; Francesca Chiarini; Lucio Cocco 2012-01-01 - - 4.03 Poster -
AMP-dependent kinase/mammalian target of rapamycin complex 1 signaling in T-cell acute lymphoblastic leukemia: therapeutic implications. Grimaldi C.; Chiarini F.; Tabellini G.; Ricci F.; Tazzari P.L.; Battistelli M.; Falcieri E.; Bort...ul R.; Melchionda F.; Iacobucci I.; Pagliaro P.; Martinelli G.; Pession A.; Barata J.T.; McCubrey J.A.; Martelli A.M. 2012-01-01 LEUKEMIA - 1.01 Articolo in rivista -
Temsirolimus, an mTOR inhibitor, in combination with lower-dose clofarabine as salvage therapy for older patients with acute myeloid leukaemia: results of a phase II GIMEMA study (AML-1107). Amadori S.; Stasi R.; Martelli A.M.; Venditti A.; Meloni G.; Pane F.; Martinelli G.; Lunghi M.; P...agano L.; Cilloni D.; Rossetti E.; Di Raimondo F.; Fozza C.; Annino L.; Chiarini F.; Ricci F.; Ammatuna E.; La Sala E.; Fazi P.; Vignetti M. 2012-01-01 BRITISH JOURNAL OF HAEMATOLOGY - 1.01 Articolo in rivista -
Effect of Lenalidomide Treatment on Lipid Signalling Pathways in Low-Risk MDS Patients Matilde Y Follo; Cristina Clissa; Sara Mongiorgi; Francesca Chiarini; Michele Baccarani; Giovanni... Martinelli; Lucia Manzoli; Alberto M Martelli; Carlo Finelli; Lucio Cocco 2011-01-01 BLOOD - 4.01 Contributo in Atti di convegno -
Preclinical testing of the Akt inhibitor triciribine in T-cell acute lymphoblastic leukemia Evangelisti C; Ricci F; Tazzari P; Chiarini F; Battistelli M; Falcieri E;
Ognibene A; Pagliaro P;...
Cocco L; McCubrey JA; Martelli AM
2011-01-01 JOURNAL OF CELLULAR PHYSIOLOGY - 1.01 Articolo in rivista -
Synergistic induction of PI-PLCbeta1 signaling by azacitidine and valproic acid in high-risk myelodysplastic syndromes Follo MY; Finelli C; Mongiorgi S; Clissa C; Chiarini F; Ramazzotti G; Paolini S; Martinelli G; Ma...rtelli AM; Cocco L 2011-01-01 LEUKEMIA - 1.01 Articolo in rivista -
Targeted inhibition of mTORC1 and mTORC2 by active-site mTOR inhibitors has cytotoxic effects in T-cell acute lymphoblastic leukemia. Evangelisti C.; Ricci F.; Tazzari P.; Tabellini G.; Battistelli M.; Falcieri E.; Chiarini F.; Bor...tul R.; Melchionda F.; Pagliaro P.; Pession A.; McCubrey J.A.; Martelli A.M. 2011-01-01 LEUKEMIA - 1.01 Articolo in rivista -
Temsirolimus, An Allosteric mTORC1 Inhibitor, Is Synergistic with Clofarabine in AML and AML Leukemia Initiating Cells CHIARINI F; GRIMALDI C; RICCI F; TAZZARI PL; IACOBUCCI I; MARTINELLI G; PAGLIARO P; MCCUBREY J; A...MADORI S; MARTELLI AM 2011-01-01 BLOOD - 4.02 Riassunto (Abstract) -